Shortage of ADHD Medication Adderall, Says FDA
The U.S. Food and Drug Administration (FDA) has announced that the drug Adderall, commonly used by individuals with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy, is in short supply. The intermittent manufacturing delays at Teva, one of the companies that produces the medication, have caused the shortage of Adderall and Adderall IR. While other companies continue to produce amphetamine mixed salts, they do not produce enough to meet the demand in the U.S.
Adderall is an FDA-approved medication for ADHD and narcolepsy. Until the supply is restored, the FDA suggests alternatives such as the extended-release version of amphetamine mixed salts. The agency has posted information online regarding current manufacturers and available product strengths. It is monitoring the shortage and assisting manufacturers in resolving it. The FDA has promised to provide updates as the situation progresses.
The FDA Center for Drug Evaluation and Research advises patients to work with their doctors to determine their best treatment option.